95 related articles for article (PubMed ID: 6275700)
1. Stability of an extemporaneous formulation of injectable cholecalciferol.
Bertino JS; Reed MD; Lambert PW; Halpin TC
Am J Hosp Pharm; 1981 Dec; 38(12):1932-3. PubMed ID: 6275700
[TBL] [Abstract][Full Text] [Related]
2. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
3. Compounding of vitamin A, D3, E and K3 supplements for cystic fibrosis patients: formulation and stability study.
Huyghebaert N; De Beer J; Vervaet C; Remon JP
J Clin Pharm Ther; 2007 Oct; 32(5):489-96. PubMed ID: 17875116
[TBL] [Abstract][Full Text] [Related]
4. Potency and stability of extemporaneous nitroglycerin infusions.
McNiff BL; McNiff EF; Fung HL
Am J Hosp Pharm; 1979 Feb; 36(2):173-7. PubMed ID: 105634
[TBL] [Abstract][Full Text] [Related]
5. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
Pabari RM; McDermott C; Barlow J; Ramtoola Z
Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
[TBL] [Abstract][Full Text] [Related]
6. Stability of a nonaqueous trimethoprim preparation.
Tu YH; Wang DP; Allen LV
Am J Hosp Pharm; 1989 Feb; 46(2):301-4. PubMed ID: 2712049
[TBL] [Abstract][Full Text] [Related]
7. Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial.
André P; Cisternino S; Chiadmi F; Toledano A; Schlatter J; Fain O; Fontan JE
Ann Pharmacother; 2005 Sep; 39(9):1462-6. PubMed ID: 15985470
[TBL] [Abstract][Full Text] [Related]
8. Physical and chemical stability of pemetrexed in infusion solutions.
Zhang Y; Trissel LA
Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
[TBL] [Abstract][Full Text] [Related]
9. Effects of compounding and storage conditions on stability of pergolide mesylate.
Davis JL; Kirk LM; Davidson GS; Papich MG
J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
[TBL] [Abstract][Full Text] [Related]
10. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
Xu QA; Trissel LA; Williams KY
J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
[TBL] [Abstract][Full Text] [Related]
11. Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags.
Trissel LA; Pearson SD
Am J Hosp Pharm; 1994 Feb; 51(3):368-72. PubMed ID: 8160690
[TBL] [Abstract][Full Text] [Related]
12. Stability of extemporaneous suspensions of carbamazepine.
Burckart GJ; Hammond RW; Akers MJ
Am J Hosp Pharm; 1981 Dec; 38(12):1929-31. PubMed ID: 7325176
[TBL] [Abstract][Full Text] [Related]
13. Stability of allopurinol and of five antineoplastics in suspension.
Dressman JB; Poust RI
Am J Hosp Pharm; 1983 Apr; 40(4):616-8. PubMed ID: 6846371
[TBL] [Abstract][Full Text] [Related]
14. Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
Lebitasy M; Hecq JD; Athanassopoulos A; Vanbeckbergen D; Jamart J; Galanti L
J Clin Pharm Ther; 2009 Aug; 34(4):423-8. PubMed ID: 19583675
[TBL] [Abstract][Full Text] [Related]
15. Stability of an extemporaneously compounded baclofen oral liquid.
Johnson CE; Hart SM
Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
[TBL] [Abstract][Full Text] [Related]
16. In vitro stability of enoxaparin solutions (20 mg/mL) diluted in 4% glucose.
Patel RP; Narkowicz C; Jacobson GA
Clin Ther; 2008 Oct; 30(10):1880-5. PubMed ID: 19014843
[TBL] [Abstract][Full Text] [Related]
17. Stability of haloperidol in 5% dextrose injection.
Das Gupta V; Stewart KR
Am J Hosp Pharm; 1982 Feb; 39(2):292-4. PubMed ID: 7058800
[TBL] [Abstract][Full Text] [Related]
18. Stability of parenteral midazolam in an oral formulation.
Walker SE; Grad HA; Haas DA; Mayer A
Anesth Prog; 1997; 44(1):17-22. PubMed ID: 9481976
[TBL] [Abstract][Full Text] [Related]
19. Dilute iron dextran formulation for addition to parenteral nutrient solutions.
Kwong KW; Tsallas G
Am J Hosp Pharm; 1980 Feb; 37(2):206-10. PubMed ID: 6767401
[TBL] [Abstract][Full Text] [Related]
20. Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation.
Garg A; Garg S; She RW
Burns; 2011 Nov; 37(7):1150-3. PubMed ID: 21764219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
